Tempus Introduces Fuses, A Program Designed To Transform Therapeutic Research And Build The Largest Diagnostic Platform Using It

Market Closed – Nasdaq			5-day change	1st Jan Change
55.18 ^USD	+1.38%		-11.80%	+63.45%

Published on 05/31/2025 at 08:31

This article is reserved for members

Unlock the article: REGISTER NOW!

Tempus Introduces Fuses, A Program Designed To Transform Therapeutic Research And Build The Largest Diagnostic Platform Using Its Novel Foundation Model	08:31am	RE
Sector Update: Tech Stocks Mixed Late Afternoon	May. 28	MT
Spruce Point Capital Management Announces Investment Opinion	May. 28	RE
Tempus AI Shares Fall After Short Seller Spruce Point Raises Concerns About Management, AI Capabilities	May. 28	MT
Tempus AI, Inc. Announces Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment	May. 20	CI
Tempus AI, Verastem to Develop Diagnostic Test for Ovarian Cancer Combination Treatment	May. 20	MT
Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment	May. 20	RE
Enterprise Development Unit Offloads Meta Platforms, Tempus AI Shares	May. 15	MT
Tempus AI Enters Collaboration With Boehringer Ingelheim to Advance Boehringer’s Cancer Pipeline	May. 14	MT
Tempus Ai, Inc. Enters Multi-Year Strategic Collaboration with Boehringer Ingelheim to Advance Its Cancer Pipeline	May. 14	CI
Biovica Collaborates with Tempus to Expand the Commercial Reach of DiviTum®? TKa	May. 13	CI
Tempus AI, Inc., Q1 2025 Earnings Call, May 06, 2025	May. 06
Tempus AI Q1 Non-GAAP Loss Narrows; Revenue Rises; Slightly Ups Full Year Guidance	May. 06	MT
Earnings Flash (TEM) Tempus AI Reports Q1 Revenue $255.7M, vs. FactSet Est of $248.1M	May. 06	MT
Earnings Flash (TEM) Tempus AI Posts Q1 Loss $-0.24 Per Share, vs. FactSet Est of $-0.28	May. 06	MT
Tempus AI, Inc. Increases Earnings Guidance for Full Year 2025	May. 06	CI
Tempus AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	May. 06	CI
Tempus Ai, Inc. Announces Notetaker, Its Ai-Powered Clinical Assistant for Psychiatry	May. 05	CI
Tempus AI, Inc. Time Network Expands Support of Phase I Clinical Trials to Accelerate Activation and Enrollment	May. 01	CI
Tempus AI, Inc. Introduces Loop, an AI-Powered Target Discovery and Validation Platform	Apr. 28	CI
Sector Update: Health Care Stocks Edge Up Late Afternoon	Apr. 23	MT
Tempus AI to Build Oncology Multimodal Foundation Model in Partnership With AstraZeneca, Pathos AI	Apr. 23	MT
Tempus AI Inc Announces Strategic Collaborations With AstraZeneca And Pathos	Apr. 23	RE
Tempus Signs Expanded Strategic Agreements with Astrazeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology	Apr. 23	CI
BTIG Initiates Tempus AI at Buy With $60 Price Target	Apr. 21	MT

Duration

Period

TEM: Dynamic Chart

Tempus AI, Inc. is a technology company. The Company provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Companyâs product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The Company’s AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.

More about the company

Sell

Buy

Average target price

65.50USD

Spread / Average Target

+18.70%

Consensus

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Bitcoin’s Bullish Pattern Predicts New All Time Highs

Tether, Blackstone Vets Raising $1 Billion for Public Bitcoin, Ethereum and Solana Treasury

Why bitcoin isn’t rallying even with billions of dollars in ETF inflows

Ripple eyeing ‘multiple acquisitions,’ Ethereum-like upgrades to XRP Ledger blockchain – DL News

How A Family Chain Outsmarted Inflation

Tokenized RWAs Surge to $24B in 2025, Led by Private Credit and Ethereum

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Bitcoin’s Bullish Pattern Predicts New All Time Highs

Tether, Blackstone Vets Raising $1 Billion for Public Bitcoin, Ethereum and Solana Treasury

Why bitcoin isn’t rallying even with billions of dollars in ETF inflows

Ripple eyeing ‘multiple acquisitions,’ Ethereum-like upgrades to XRP Ledger blockchain – DL News

How A Family Chain Outsmarted Inflation

Tokenized RWAs Surge to $24B in 2025, Led by Private Credit and Ethereum

Tempus Introduces Fuses, A Program Designed To Transform Therapeutic Research And Build The Largest Diagnostic Platform Using Its Novel Foundation Model

Related Posts

Jim Cramer’s top 10 things to watch in the stock market Thursday

Bitcoin’s Bullish Pattern Predicts New All Time Highs

Tether, Blackstone Vets Raising $1 Billion for Public Bitcoin, Ethereum and Solana Treasury

ETFs and corporate treasuries should support bitcoin's uptrend in June

Ethereum's 50% rally setup vs. Bitcoin sparks altseason hopes

Arvinas And Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival For Patients With Esr1-Mutant, Er+/Her2- Advanced Breast Cancer

Recent Posts

Navigate Site

Tempus Introduces Fuses, A Program Designed To Transform Therapeutic Research And Build The Largest Diagnostic Platform Using Its Novel Foundation Model

Related Posts

Recent Posts

Navigate Site

Follow Us